Data as of Apr 16
| +0.73 / +3.83%|
The 5 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 40.00, with a high estimate of 55.00 and a low estimate of 35.00. The median estimate represents a +102.33% increase from the last price of 19.77.
The current consensus among 5 polled investment analysts is to Buy stock in PTC Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.